BioCardia - Warrants (26/07/2022)'s total liabilities is $2.1M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), BCDAW shows a total liabilities of $2.1M. That compares with $4M in the prior-year period — down 48.3% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, BCDAW's total liabilities is now $2.1M (was $4M) — a 48.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether BioCardia - Warrants (26/07/2022) is outperforming or lagging.
Tracking BCDAW's total liabilities over time shows whether BioCardia - Warrants (26/07/2022) is scaling, shrinking, or reshaping that part of the business. The current reading is $2.1M That compares with $4M in the prior-year period — down 48.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total liabilities page, Stockcircle has BioCardia - Warrants (26/07/2022)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $2.1M) with ownership activity and broader fundamentals.
BioCardia - Warrants (26/07/2022)'s total liabilities is $2.1M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.